Literature DB >> 22298983

New cytokine targets in inflammatory bowel disease.

Thomas T Macdonald1.   

Abstract

Entities:  

Year:  2011        PMID: 22298983      PMCID: PMC3264897     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


× No keyword cloud information.
  5 in total

1.  Inside the microbial and immune labyrinth: totally gutted.

Authors:  Thomas T Macdonald
Journal:  Nat Med       Date:  2010-11       Impact factor: 53.440

2.  Infliximab, azathioprine, or combination therapy for Crohn's disease.

Authors:  Jean Frédéric Colombel; William J Sandborn; Walter Reinisch; Gerassimos J Mantzaris; Asher Kornbluth; Daniel Rachmilewitz; Simon Lichtiger; Geert D'Haens; Robert H Diamond; Delma L Broussard; Kezhen L Tang; C Janneke van der Woude; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2010-04-15       Impact factor: 91.245

Review 3.  Regulation of homeostasis and inflammation in the intestine.

Authors:  Thomas T MacDonald; Ivan Monteleone; Massimo Claudio Fantini; Giovanni Monteleone
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

Review 4.  IL-21 comes of age as a regulator of effector T cells in the gut.

Authors:  M C Fantini; G Monteleone; T T MacDonald
Journal:  Mucosal Immunol       Date:  2008-01-23       Impact factor: 7.313

5.  A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.

Authors:  William J Sandborn; Brian G Feagan; Richard N Fedorak; Ellen Scherl; Mark R Fleisher; Seymour Katz; Jewel Johanns; Marion Blank; Paul Rutgeerts
Journal:  Gastroenterology       Date:  2008-07-17       Impact factor: 22.682

  5 in total
  3 in total

Review 1.  An Emerging Role for SNARE Proteins in Dendritic Cell Function.

Authors:  Laura E Collins; Joseph DeCourcey; Mariana Soledad di Luca; Keith D Rochfort; Christine E Loscher
Journal:  Front Immunol       Date:  2015-03-31       Impact factor: 7.561

2.  Top-100 highest-cited original articles in inflammatory bowel disease: A bibliometric analysis.

Authors:  Xinrong Chen; Kun Yang; Yujie Xu; Ka Li
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 3.  Microbiome, Metabolome and Inflammatory Bowel Disease.

Authors:  Ishfaq Ahmed; Badal C Roy; Salman A Khan; Seth Septer; Shahid Umar
Journal:  Microorganisms       Date:  2016-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.